Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Canberra
Clinical trial register · Australia

Clinical Trials in Canberra, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Kirby Institute3 Clinical Hub for Interventional Research (CHOIR)3 Novo Nordisk A/S2 Incyte Corporation2 Janssen Research & Development, LLC1
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Canberra

36 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Canberra, Camperdown, Wollongong, Chermside, Douglas, Milton, Rockhampton, Sippy Downs
2026-10-26
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Canberra, Liverpool, Chelmer, Chermside, Ipswich, Milton, Adelaide, Bedford Park
2026-05-11
Not yet open
Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis
NCT07435636Clonal Cytopenia of Uncertain Significance, CCUS Clonal Cytopenia of Undetermined Significance, Clonal Hematopoiesis
Clinical Hub for Interventional Research (CHOIR)
Phase 2
80
Canberra, Randwick, Westmead
2026-04-13
Recruiting
Incyte Corporation
Phase 3
588
Macquarie Park, Chermside, Townsville, Woodville South, Melbourne, Richmond, Canberra, Perth
2026-04-09
Recruiting
CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
NCT07313059Clonal Hematopoiesis, CCUS Clonal Cytopenia of Undetermined Significance, Hematologic Disease and Disorders
Clinical Hub for Interventional Research (CHOIR)
Observational
100
Canberra
2026-03-20
Recruiting
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
NCT07276139Cardiomyopathy, Secondary, Arrhythmias, Cardiac, Heart Failure, Pacing Induced Cardiomyopathy
Insel Gruppe AG, University Hospital Bern
Observational
4,500
Canberra
2026-01-01
Recruiting
European Myeloma Network B.V.
Phase 3
1,000
Adelaide, Box Hill, Canberra, Geelong, Heidelberg, Kingswood, Melbourne, Sunshine Coast
2025-12-23
Recruiting
Eli Lilly and Company
Phase 3
1,205
Box Hill, Brisbane, Canberra, Geelong, Meadowbrook, Perth, Southport, St Leonards
2025-10-31
Recruiting
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
NCT06819592All-cause Mortality, Quality of Life, Disability, Intellectual, Neurological Disorder
The George Institute
Phase 3
3,300
Canberra, Camperdown, Darlinghurst, Dubbo, Kingswood, Kogarah, Liverpool, Randwick
2025-10-30
Recruiting
OM336 in Autoimmune Cytopenias
NCT07083960AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia, ITP - Immune Thrombocytopenia
Lakefront Biotherapeutics West LLC
Phase 1
32
Canberra, Sydney, Brisbane
2025-08-01
Recruiting
Marea Therapeutics
Phase 2
316
Canberra, Kanwal, Merewether, Miranda, Wollongong, Herston, Milton, Leabrook
2025-06-30
Recruiting
XII Medical
Not applicable
30
Canberra, Sydney, Wollongong, Brisbane, Perth
2025-06-24
Recruiting
Clinical Hub for Interventional Research (CHOIR)
Observational
25
Canberra, Sydney, Westmead
2025-06-06
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Canberra, North Tamworth, Orange, Brisbane, Elizabeth Vale, Frankston, Melbourne, Traralgon
2025-04-24
Recruiting
Maintenance rTMS for Depression (Maitr-De)
NCT06938841Major Depressive Disorder, Treatment Resistant Depression
University of California, San Diego
Not applicable
75
Canberra
2025-04-01
Active, closed
Gilead Sciences
Phase 3
640
Canberra, Camperdown, South Brisbane, Clayton, Melbourne, Murdoch
2024-08-28
Recruiting
Fibrinolysis Resistance in Infection and Trauma
NCT06680180Sepsis and Septic Shock, Trauma
Anders Aneman
Observational
150
Canberra, Liverpool, Macquarie, St Leonards
2024-06-01
Recruiting
AstraZeneca
Phase 3
3,850
Blacktown, Cairns, Canberra, Chermside, Clayton, Concord, Frankston, Geelong
2024-04-12
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Canberra, Clayton, Concord, Herston, Liverpool, Perth, Southport, St Albans
2024-03-29
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Campbelltown, Canberra, East Melbourne, Greenslopes, Melbourne
2024-01-17
Recruiting
A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
NCT05325008BK Viremia, Kidney Transplant Infection, Kidney Transplant Failure and Rejection
DrugImmunoglobulin
The University of Queensland
Phase 3
280
Canberra, New Lambton Heights, Randwick, Sydney, Westmead, Brisbane, Townsville, Woolloongabba
2023-08-18
Recruiting
Cystetic Medicines, Inc.
Phase 1
108
Canberra, Westmead, Brisbane, Clayton
2023-03-21
Recruiting
Kirby Institute
Observational
40,000
Canberra, Sydney, Bowen Hills, Brisbane, Cairns, Townsville, Woodford, Adelaide
2023-02-23
Active, closed
University Medical Center Groningen
Phase 3
1,750
Canberra, New Lambton Heights, Sydney, Wollongong, Birtinya, Brisbane, Douglas, Adelaide
2022-11-08
Recruiting
Kirby Institute
Observational
60,000
Canberra, Bathurst, Broken Hill, Coffs Harbour, Gosford, Inverell, Lismore, Newtown
2022-02-23
Recruiting
Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease
NCT05136222Motor Neuron Disease / Amyotrophic Lateral Sclerosis
University of Melbourne
Not applicable
244
Adelaide, Brisbane, Canberra, Melbourne, Perth, Sydney
2021-12-15
Active, closed
Galecto Biotech AB
Phase 2
21
Canberra
2021-06-09
Active, closed
Incyte Corporation
Phase 3
899
Adelaide, Ballarat, Birtinya, Brisbane, Canberra, Clayton, Frankston, Geelong
2021-05-11
Recruiting
Efemoral Medical, Inc.
Not applicable
100
Sydney, Canberra, Melbourne
2020-09-22
Active, closed
BeOne Medicines
Phase 3
955
Canberra, Concord, East Albury, Kogarah, St Leonards, Waratah, Westmead, Auchenflower
2020-01-16
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Adelaide, Brisbane, Camperdown, Canberra, Douglas, Hobart, Launceston, Melbourne
2019-03-01
Recruiting
The EXCEL Registry of Patients Requiring ECMO
NCT03793257Critically Ill, Acute Respiratory Failure, Acute Heart Failure, Cardiac Arrest
Australian and New Zealand Intensive Care Research Centre
Observational
3,000
Canberra, Camperdown, Darlinghurst, Liverpool, Newcastle, St Leonards, Sydney, Westmead
2019-02-01
Recruiting
Kirby Institute
Not applicable
6,000
Canberra, Blacktown, Brookvale, Campbelltown, Cessnock, Coffs Harbour, Darlinghurst, Grafton
2018-05-28
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Canberra, Elizabeth Vale, Liverpool, Sydney, Westmead
2018-05-14
Active, closed
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Canberra, Campbelltown, Camperdown, Darlinghurst, Gateshead, Gosford, Liverpool, Newcastle
2017-08-21
Recruiting
UMC Utrecht
Phase 3
20,000
Canberra, Bankstown, Blacktown, Campbelltown, Caringbah, Concord, Dubbo, Frenchs Forest
2016-04-11
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/canberra

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Canberra.

How many clinical trials are recruiting in Canberra?

24 of the 36 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Canberra), 36 studies
PhaseStudiesRecruitingShare
Phase 317947.2%
Observational8722.2%
Not applicable6516.7%
Phase 2318.3%
Phase 1225.6%

Most active sponsors

Lead sponsors with the most studies (Canberra)
Lead sponsorStudiesRecruiting
Clinical Hub for Interventional Research (CHOIR)32
Kirby Institute33
Incyte Corporation21
Novo Nordisk A/S21
Alexion Pharmaceuticals, Inc.10
Anders Aneman11
AstraZeneca11
Australian and New Zealand Intensive Care Research Centre11
BeOne Medicines10
Biotronik SE & Co. KG10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.